590 related articles for article (PubMed ID: 19185372)
21. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.
Lokuge A; Lam L; Cameron P; Krum H; de Villiers S; Bystrzycki A; Naughton MT; Eccleston D; Flannery G; Federman J; Schneider HG
Circ Heart Fail; 2010 Jan; 3(1):104-10. PubMed ID: 19933409
[TBL] [Abstract][Full Text] [Related]
22. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M
J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645
[TBL] [Abstract][Full Text] [Related]
23. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M
Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203
[TBL] [Abstract][Full Text] [Related]
24. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
25. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
[TBL] [Abstract][Full Text] [Related]
26. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
[TBL] [Abstract][Full Text] [Related]
27. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
28. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.
Mueller C; Laule-Kilian K; Schindler C; Klima T; Frana B; Rodriguez D; Scholer A; Christ M; Perruchoud AP
Arch Intern Med; 2006 May; 166(10):1081-7. PubMed ID: 16717170
[TBL] [Abstract][Full Text] [Related]
30. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
[TBL] [Abstract][Full Text] [Related]
31. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study.
Knudsen CW; Omland T; Clopton P; Westheim A; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
J Am Coll Cardiol; 2005 Sep; 46(5):838-44. PubMed ID: 16139134
[TBL] [Abstract][Full Text] [Related]
32. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea.
Rogers RK; Stoddard GJ; Greene T; Michaels AD; Fernandez G; Freeman A; Nord J; Stehlik J
Am J Cardiol; 2009 Sep; 104(5):689-94. PubMed ID: 19699346
[TBL] [Abstract][Full Text] [Related]
34. [BNP/NT-proBNP: what is the best choice in an emergency laboratory?].
Collin-Chavagnac D; Jacques D; Perrin M; Rabilloud M; Manchon M
Ann Biol Clin (Paris); 2006; 64(3):275-80. PubMed ID: 16698565
[TBL] [Abstract][Full Text] [Related]
35. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
36. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
37. The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea.
Breidthardt T; Noveanu M; Cayir S; Viglino M; Laule K; Hochholzer W; Reichlin T; Potocki M; Christ M; Mueller C
Int J Cardiol; 2009 Aug; 136(2):193-9. PubMed ID: 18619686
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
39. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
[TBL] [Abstract][Full Text] [Related]
40. [B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea].
Knudsen CW; Westheim A; Omland T
Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2045-8. PubMed ID: 12934128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
